Zobrazeno 1 - 10
of 26
pro vyhledávání: '"José Miguel Ferrari-Piquero"'
Publikováno v:
Farmacia Hospitalaria, Vol 42, Iss 01, Pp 5-9 (2018)
Objective: To analyse the effectiveness and safety of oral antineoplastic drugs (ANEOs) that are authorized in special situations in a third-level hospital and to compare the results obtained with the clinical evidence used for this authorization. M
Externí odkaz:
https://doaj.org/article/3574fb80a3c44e71af96653a352cb9cd
Autor:
Álvaro González Gómez, Verónica Monsálvez Honrubia, Lucía Alonso Pérez, José Miguel Ferrari Piquero
Publikováno v:
Pharmaceutical Care España, Vol 26 (2024)
La enfermedad de Hailey-Hailey es una enfermedad minoritaria dermatológica de origen genético. Cursa con la aparición de lesiones ampollosas, especialmente en áreas de fricción y pliegues cutáneos, como la región inguinal, axilar y el cuello.
Externí odkaz:
https://doaj.org/article/68cef96367d141568a87ff18ec051799
Autor:
Andrea Lázaro Cebas, José Manuel Caro Teller, Carmen García Muñoz, Carlos González Gómez, José Miguel Ferrari Piquero, Carlos Lumbreras Bermejo, José Antonio Romero Garrido, Juana Benedí González
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its
Externí odkaz:
https://doaj.org/article/f49b14ba5bae4a6899bced58d2d6280b
Autor:
Dolores Canales-Siguero, Carmen García-Muñoz, Pilar Quijada Fraile, Montserrat Morales Conejo, José Miguel Ferrari-Piquero, Elena Martín-Hernández
Publikováno v:
Medicina Clínica (English Edition). 159:380-384
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d4cec99328f526eb7513ac7839e2c10
https://doi.org/10.1016/j.medcle.2022.09.002
https://doi.org/10.1016/j.medcle.2022.09.002
Autor:
Dolores Canales-Siguero, Carmen García-Muñoz, Pilar Quijada Fraile, Montserrat Morales Conejo, José Miguel Ferrari-Piquero, Elena Martín-Hernández
Publikováno v:
Medicina Clínica. 159:380-384
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f466ed7600c5b13b19189b81fffe7e9
https://doi.org/10.1016/j.medcli.2022.02.006
https://doi.org/10.1016/j.medcli.2022.02.006
Autor:
Susana Cortijo-Cascajares, Ana Cristina Cercós-Lletí, Sara Ortiz-Pérez, José Manuel Caro-Teller, José Miguel Ferrari-Piquero
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:290-298
Objective To study immune-related adverse events (irAEs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab, as well as to assess whether these reactions could be predictors of further effectiveness of therapy. Methods Retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc0af0e3f68d4ce64bb4f38d2652ac3
https://doi.org/10.1177/10781552211067429
https://doi.org/10.1177/10781552211067429
Autor:
Carmen Garcia-Muñoz, Jose Manuel Caro-Teller, Pedro Pablo Rodríguez Quesada, Almudena Añino Alba, José Miguel Ferrari Piquero, María Luisa Ibarra Mira
Publikováno v:
J Pharm Technol
Background: A significant percentage of hospital readmissions within 30 days of discharge are a result of avoidable drug-related problems. Stratifying patients according to readmission risk is key to pharmaceutical intervention (PI) design strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c45569cfccffbc73beb15fb5249bd4e
https://doi.org/10.1177/87551225211047607
https://doi.org/10.1177/87551225211047607
Autor:
Miguel Ángel, Bruni-Montero, José Manuel, Caro-Teller, José Antonio, Hernández-Ramos, Cristian, Rosas-Espinoza, Dolores, Canales-Siguero, José Miguel, Ferrari-Piquero
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(1)
The combination of selective serotonin reuptake inhibitors with rivaroxaban may result in a dual interaction (pharmacokinetic and pharmacodynamic) depending on the type of selective serotonin reuptake inhibitor employed (CYP3A4-inhibiting vs. non-CYP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f05242d6739968caffd2ac61606e981
https://pubmed.ncbi.nlm.nih.gov/35379086
https://pubmed.ncbi.nlm.nih.gov/35379086
Autor:
José Antonio, Hernández-Ramos, José Manuel, Caro-Telle, Miguel Ángel, Bruni-Montero, Dolores, Canales-Siguero, José Miguel, Ferrari-Piquero
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 45(6)
The literature has described the interaction between valproic acid and carbapenems. This interaction leads to decreases in plasma concentrations of valproic acid. The main objectives of this study were to assess its relevance in clinical practice, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5544fda23693b5cc5f3d63787607422
https://pubmed.ncbi.nlm.nih.gov/34806574
https://pubmed.ncbi.nlm.nih.gov/34806574
Autor:
Carmen Garcia-Muñoz, José Miguel Ferrari Piquero, Miguel Angel Granados Ruíz, Dolores Canales Siguero, Francisco Martínez de la Torre
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:862-864
What is known and objective In paediatrics, evidence regarding the treatment of viral myocarditis using interferon beta-1B is restricted to four children older than two years and there are no reported cases of infants. The objective was to describe t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ced59cb25e981612182cd022e67ad236
https://doi.org/10.1111/jcpt.13357
https://doi.org/10.1111/jcpt.13357